首页行业分类金融证券证券2023-03-24-国金证券-普洛药业-成本逐步回落,盈利水平有望改善
PDF

2023-03-24-国金证券-普洛药业-成本逐步回落,盈利水平有望改善

若****74页792.18K

下载文档
/4
全屏查看
2023-03-24-国金证券-普洛药业-成本逐步回落,盈利水平有望改善
还有 4 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 4 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
国金证券公司点评2020202120222023E2024E2025E2020202120222023E2024E2025E10,545121781425716,1602,1942.6103,5533,8184,8835,83813.5%17.915.5%17.1%13.4%应收款项1,2681,5472,0672,2282.5942,972-5,677-8,024-8,964-10,317-11,5791,2501,8021,8962,0012,24672.0%73.5%71.7%其他流动资产39375455501544毛利2,2032,3732,5213,2143,9404.5814,9175,7827,7818.39711,64928.0%26.5%23.9%283%感资产65.63.16466.070.1-33-32-43501221911912913910.5%0.441,9812,6423,5807203,851-574-453535-670-75626.428.8%28.2523.2%销售收入7.3%5.5%5.3%37243642553162307-454-450-609-699-7922,5773,3814,2354,3304,6604,973销售收入4.9%4.3%5.0%4.9%49%34.0%31.8%29.95研发费用-350-446-670-7565.0%5.1%5.5%5.3%3303465724235545959879711,2231,6802,084应付款项2,7604,4395875.280592610.9%11.0%9.2%11.812.9%其他流动负债5306738419631,0951410616975392,8963,7790275,8516,7977,6160.8%-1.0%-0.2105250455470500-34-48-1920321922126262647-24-23-15-10-103.1044,1034976,3318,14262904.3915.0605,5126,3887,3398,4736.5%8.1n.a413.2%1,1791,1791,1791,1791,1791,1799701,1191,0121,4671,8542,211未分配利润2,6093,2403,8554,6075.55812.3%12.5%12.0%13.0%13.7%077营业外收支-9-500009611,1140121,4671.8542,2119.6线120%13.0%13.7%-144-159-23-213-269-3212020202120222023E2024E2025E15.0%2.3%14.5%14.5%8179569891,2541,5851,8900.6930.8110.83910641.3451.604000003.7264.2944.6775.4207.1909569891,2541,560.8990.5191.1251.3592.1522.32510.4%10.7%9.4%10.3%11.7%0.0000.0000.0000.4260.5380.64218.60%8817.95%19.64%21.60%22.312020202120222023E2024E2025E10.90%10.43%8.239.8610.83%11.37%8179569891,2541.5851.89015.3815.35%17.16线18.6100004104725836370813491792154817.07%13.35%-87-7116032EBIT增长率15.22525.37.3924.04%93-668-39629710947.58%3.5226.82%26.36线19.24561214.91%22.26%31.14%15.02%13.55%资本开支-300-698504-824868919产力-15-1-1048.951.653.952.05151.0249081-400-5066.864.9478.071.571.5106-515-591-87997975.070.870.070.070000123084.478.8106.190.574.561.9280107-2114672其他-201-311576-560-699828-45.10-49.45-56.579-204-196-45812.9-9.2-7.3-22.4-53.11.206-12558326541.42%44.78%54.07%49.75%49.81%2